GlassScriptPhysician profile
Todd Snyder
NPI 1093258188
$427,368.31
in general payments reported to CMS, 2019-2025
22 companies · $66K in 2025
The $66K reported for 2025 was more than what 99% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30K · 2020: $50K · 2021: $46K · 2022: $85K · 2023: $78K · 2024: $71K · 2025: $66K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $160K · Consulting Fee: $35K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,681 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $5,000 · Education: $2,418 · Royalty Or License: $2,000 · Gift: $1,543 · Travel and Lodging: $1,363 · Other payment types: $625.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $159,632.91 |
| Consulting Fee | $34,993.89 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,680.81 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $5,000.00 |
| Education | $2,418.17 |
| Royalty Or License | $2,000.00 |
| Gift | $1,542.63 |
| Travel and Lodging | $1,363.00 |
| Other payment types | $624.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bisco, INC. | $117,384.72 | 2019-2025 | |
| Ultradent Products INC | $82,128.48 | 2019-2025 | Opalescence |
| Gc America INC. | $75,478.73 | 2019-2025 | Mi Paste, G-Aenial, G-Cem |
| Dmg America LLC | $43,896.47 | 2019-2025 | Ecosite Elements, Luxatemp, Ecosite Bulk Fill |
| Pulpdent Corporation | $41,000.00 | 2019-2025 | |
| Doxa Dental, INC. | $24,750.00 | 2019-2021 | |
| Clinician'S Choice Dental Products INC. | $8,413.43 | 2020 | |
| Peter Brasseler Holdings, LLC | $7,639.92 | 2025 | |
| Shofu Dental Corp | $5,500.00 | 2023-2024 | |
| Dental Imaging Technologies Corp. | $5,281.25 | 2021 | |
| Envista Holdings Corporation | $4,529.24 | 2024-2025 | |
| Kettenbach LP | $2,750.00 | 2022 | |
| Kerr Corporation | $1,773.11 | 2019 | |
| Ivoclar Vivadent, INC. | $1,711.70 | 2020-2022 | |
| Dentsply LLC | $1,700.00 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Den-Mat Holdings, LLC | $1,500.00 | 2025 | |
| Garrison Dental Solutions | $1,482.00 | 2025 | Quad Sectional Matrix System Deluxe Kit, Quad Tall Ring: 2 Per Package, Lm-Arte Dark Diamond Set |
| 3m Company | $200.00 | 2021 | |
| Patterson Companies, INC. | $125.37 | 2023-2025 | |
| Voco America INC. | $51.00 | 2019 | |
| Henry Schein One, LLC | $40.89 | 2025 | |
| Nobel Biocare USA | $32.00 | 2023 | Nobelactive |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Snyder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.